Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative Pathogens

Due to limited new antibiotics, polymyxins are increasingly used to treat multidrug-resistant (MDR) Gram-negative bacteria, in particular carbapenem-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Unfortunately, polymyxin monotherapy has led to the emergence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Thien B., Wang, Jiping, Doi, Yohei, Velkov, Tony, Bergen, Phillip J., Li, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906568/
https://www.ncbi.nlm.nih.gov/pubmed/29706941
http://dx.doi.org/10.3389/fmicb.2018.00721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906568/
https://www.ncbi.nlm.nih.gov/pubmed/29706941
http://dx.doi.org/10.3389/fmicb.2018.00721

Ejemplares similares